Tissue Engineering, 3D Bioprinting, Bioink, Biotechnology, Drug Development Tools
VoxCell BioInnovation has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
VoxCell BioInnovation's investors include Archangel Network of Funds, Ventioneers, Spring Activator, New Ventures BC, WUTIF.
VoxCell BioInnovation is headquartered in Victoria, Canada.
Tissue Engineering, 3D Bioprinting, Bioink, Biotechnology, Drug Development Tools
VoxCell BioInnovation is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VoxCell BioInnovation — Funding & Investors." VCBacked, March 21, 2025, https://www.vcbacked.co/company/voxcell-bioinnovation. Accessed September 16, 2026.
VCBacked. (2025). VoxCell BioInnovation — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/voxcell-bioinnovation
{{cite web |title=VoxCell BioInnovation — Funding & Investors |url=https://www.vcbacked.co/company/voxcell-bioinnovation |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated